J. Giermek

Breast cancer in young women

K. Pogoda, A. Jagiełło-Gruszfeld, A. Niwińska, 2015 .

Treatment of breast cancer during pregnancy: an observational study.

T. Fehm, B. van Calster, M. lenhard, 2012, The Lancet. Oncology.

Abstract S5-04: Ten year follow-up of BCIRG-006 comparing doxorubicin plus cyclophosphamide followed by docetaxel (AC→T) with doxorubicin plus cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in HER2+ early breast cancer

J. Mackey, N. Robert, V. Valero, 2016 .

Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study.

T. Fehm, B. van Calster, P. Neven, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapy.

M. Krzakowski, J. Walewski, P. Wiechno, 2002, Cytokines, cellular & molecular therapy.

Abstract S6-2: 313 Patients with Breast Cancer during Pregnancy — Results from a Prospective and Retrospective Registry (GBG-20/BIG02-03)

T. Fehm, M. lenhard, S. Loibl, 2010 .

313 Patients with breast cancer during pregnancy – a prospective and retrospective registry (GBG-20 / BIG02-03)

T. Fehm, M. lenhard, S. Loibl, 2010 .

Treatment of breast cancer during pregnancy: an observational study.

T. Fehm, M. lenhard, P. Westenend, 2012, The Lancet. Oncology.